GE HealthCare Technologies reported lower-than-expected Q1 2026 earnings and cut its full-year earnings guidance due to a supplier-related recall impacting profits. The stock dropped 13.2% following the announcement. Subsequently, the company's CFO announced his resignation, prompting an interim appointment. Investors who suffered losses are being invited to inquire about potential claims for recovery as the Law Offices of Frank R. Cruz investigates possible securities law violations by GE HealthCare.
Inno Holdings Inc. announced that its common stock will resume trading on The Nasdaq Capital Market starting July 31, 2026, after a trading halt was imposed on June 12, 2026, due to unusual trading activities. The company stated it is unaware of any ...
Peapack-Gladstone Financial Corporation announced a quarterly cash dividend of $0.05 per share, payable on August 27, 2026, to shareholders of record as of August 13, 2026. The company is a New Jersey-based bank holding firm with $8 billion in assets...
iBUYPOWER, known for gaming PCs, has expanded into professional workstations with its new iBUYPOWER PRO line, targeting creative and technical professionals. These systems feature high-end Intel and AMD CPUs, NVIDIA and AMD GPUs, and come with a new ...
60 Degrees Pharmaceuticals announced a private placement offering of 574,713 shares and warrants at $1.74 each, expected to raise about $1 million before fees. The offering includes series A and B warrants exercisable at $1.49 per share, with expirat...
Glaukos reported a better-than-expected Q2 2026 with an adjusted loss of $0.14 per share, beating estimates, and revenues up 50% to $185.6 million, driven by strong sales of its iDose TR product. The company raised its 2026 sales guidance to $680-$70...
